Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study

2017 ◽  
Vol 112 (11) ◽  
pp. 1709-1718 ◽  
Author(s):  
I Ordás ◽  
E Domènech ◽  
M Mañosa ◽  
V García-Sánchez ◽  
E Iglesias-Flores ◽  
...  
2011 ◽  
Vol 45 (4) ◽  
pp. 380-381 ◽  
Author(s):  
Tamás Molnár ◽  
Klaudia Farkas ◽  
Tibor Nyári ◽  
Zoltán Szepes ◽  
Ferenc Nagy ◽  
...  

Author(s):  
Raúl Vicente Olmedo Martín ◽  
Víctor Amo Trillo ◽  
Rocío González Grande ◽  
Miguel Jiménez Pérez

Author(s):  
Sara Santos ◽  
Verónica Gamelas ◽  
Rita Saraiva ◽  
Guilherme Simões ◽  
Joana Saiote ◽  
...  

Tofacitinib has emerged as a new option for ulcerative colitis. Its rapid absorption, metabolism, and clinical improvement make it an interesting option for rescue therapy in acute severe ulcerative colitis (ASUC), a situation with limited therapeutic options in patients with a long-term disease course and multiple drug failure. The management of ASUC in this setting becomes challenging, underlying the need for new drugs and data on their efficacy and safety. We describe 2 cases of acute episodes in which tofacitinib was used as a rescue therapy.


2009 ◽  
Vol 104 ◽  
pp. S474
Author(s):  
Hitoshi Ichikawa ◽  
Taku Kobayashi ◽  
Tadakazu Hisamatsu ◽  
Susumu Okamoto ◽  
Toshifumi Hibi

2010 ◽  
Vol 105 ◽  
pp. S446 ◽  
Author(s):  
Peter Mannon ◽  
Remo Panaccione ◽  
Philip Miner ◽  
Arthur McAllister ◽  
John OʼGorman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document